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Abstract
Background:  Horseradish Peroxidase (HRP) plays important roles in many biotechnological
fields, including diagnostics, biosensors and biocatalysis. Often, it is used in immobilised form. With
conventional immobilisation techniques, the enzyme adheres in random orientation: the active site
may face the solid phase rather than bulk medium, impeding substrate access and leading to sub-
optimal catalytic performance. The ability to immobilise HRP in a directional manner, such that the
active site would always face outwards from the insoluble matrix, would maximise the immobilised
enzyme's catalytic potential and could increase HRP's range of actual and potential applications.
Results: We have replaced arginine residues on the face of glycan-free recombinant HRP opposite
to the active site by lysines. Our strategy differs from previous reports of specific HRP
immobilisation via an engineered affinity tag or single reactive residue. These conservative Arg-to-
Lys substitutions provide a means of multipoint covalent immobilisation such that the active site
will always face away from the immobilisation matrix.
One triple and one pentuple mutant were generated by substitution of solvent-exposed arginines
on the "back" of the polypeptide (R118, R159 and R283) and of residues known to influence stability
(K232 and K241). Orientated HRP immobilisation was demonstrated using a modified
polyethersulfone (PES) membrane; the protein was forced to orientate its active site away from the
membrane and towards the bulk solution phase.
Mutant properties and bioinformatic analysis suggested the reversion of K283R to improve
stability, thus generating two additional mutants (K118/R159K and R118K/K232N/K241F/R283K).
While most mutants were less stable in free solution than wild type rHRP, the quadruple revertant
regained some stability over its mutant counterparts. A greater degree of immobilisation on CNBr-
activated Sepharose™ was noted with increased lysine content; however, only marginal gains in
solvent stability resulted from immobilisation on this latter matrix.
Conclusion: Directional, orientated, immobilisation of rHRP mutants onto an activated, modified
polyethersulfone membrane has been achieved with excellent retention of catalytic activity;
however, re-engineering of acceptable stability characteristics into the "immobilisation mutants"
will determine their applicability in diagnosis and biosensor development.
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Background
The peroxidase from horseradish roots (Armoracia rusti-
cana; HRP, isoform C) is the most widely studied peroxi-
dase, due mainly to its many diverse uses in
biotechnology [1]. Several reports of HRP immobilisation
exist, commonly employing adsorption as the immobili-
sation technique [2-4]. Although simple to implement,
this approach suffers from several drawbacks, including
the removal of adsorbed protein by stringent washing,
high contamination (due to non-specific protein binding)
and denaturation of proteins adsorbed onto hydrophobic
surfaces [5]. Covalent immobilisation of proteins offers a
more robust approach. Traditionally, immobilisation of
plant HRP relied on periodate oxidation of the enzyme's
carbohydrates. In recent years, however, immobilisation
technology has developed rapidly, primarily due to the
increase in number and range of activated solid supports
and the ability to engineer or chemically modify biomol-
ecules to enable easier covalent attachment. Several pro-
tein-engineering strategies have introduced reactive
amino acids to promote directed protein immobilisation,
with lysine being the most common. Abian and co-work-
ers [6] selected asparagine, glutamic acid or arginine resi-
dues of Pencillin G Acylase (PGA) for replacement by
lysine; these substitutions resulted in improved thermal
stability of the immobilised PGA, due to multipoint
attachment to a glyoxyl agarose-activated solid phase.
HRPC is a highly cationic protein that contains twenty-
one arginine residues [7]; however, only Arg residues on
the opposite side to the active site entrance were consid-
ered for substitution in the present study, as attachment to
the solid phase via the "back" of the molecule should
allow an orientated rHRP immobilisation. This primary
condition was supplemented with additional structural
criteria (e.g. avoidance of helices, position in relation to
the active site entrance, exposure to solvents) and led to
the substitution of Arg118, Arg159 and Arg283 (Figure 1)
by lysines, thus permitting the investigation of orientated
covalent attachment to two activated solid phases, poly-
ethersulfone membrane and CNBr-activated Sepharose™.
Results
Immobilisation on PES Membrane
Use of a modified PES membrane permitted successful
orientated rHRP immobilisation. Introduction of Arg to
Lys substitutions (Mutant 1; Table 1) on the opposite face
of the molecule to the active site, together with the
removal of wildtype reactive lysine residues (Mutant 3,
Table 1; see also Figure 1), forces the protein to orientate
its active site away from the membrane and towards the
bulk solution phase during covalent immobilisation. Fig-
ure 2 demonstrates faster and more intense colour devel-
opment for Mutant 3 over an eighteen-hour period
compared with wildtype. Densitometrical analysis (see
Table 2) using Image J software confirms and underscores
this point. Equal concentrations of Mutant 1, Mutant 2
(Mutant 1 with reversion at position 238), Mutant 3,
Mutant 4 (see Table 1), and wildtype rHRP were applied
(see Methods). Increased catalytic activity towards DAB
substrate is attributed to optimal orientation of the rHRP
molecule (Mutant 3), in contrast to the random orienta-
tion of wildtype rHRP or reduced binding capabilities of
K283R revertants (Mutants 2 and 4). Furthermore, this
experimental set-up also demonstrated reusability. Immo-
bilised Mutant 3 was stained repeatedly (up to three
times, data not shown) with TMB (non-precipitating sub-
strate) over a period of several hours, with appreciable cat-
alytic activity noted each time.
The twenty-one arginine residues in HRP Figure 1
The twenty-one arginine residues in HRP. Those shown in 
black are the three (R118, R159, R283) selected for mutation 
to lysine, to enable orientated rHRP immobilisation. The 
arrow indicates the active site entrance, whilst the substi-
tuted lysine residues are also highlighted (232, Ψ; 241, *)
Arg118 
Arg159 
Arg283 

Ψ
Table 1: HRP mutants described in this paper
Name Mutations
Mutant 1 R118K, R159K, R283K.
Mutant 2 R118K, R159K.
Mutant 3 R118K, R159K, K232F, K241N, R283K.
Mutant 4 R118K, R159K, K232F, K241N.
R, Arg; K, Lys. The numbering system is based on the HRP structure 
with the PDB accession number 1ATJ.BMC Biotechnology 2007, 7:86 http://www.biomedcentral.com/1472-6750/7/86
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Stability Properties of Arg → Lys Mutants
Stabilities in free solution of Mutants 1–4 were compared
with wildtype. Mutant 1 displayed almost identical ther-
mal and solvent stabilities (except in MeOH) to wildtype
rHRP. Mutant 3 was notably less stable (50% decrease in
thermal and 20% decrease in MeOH stabilities). This was
unexpected, as the chemically modifiable proximal lysine
residues (232 and 241, [8]) had been mutated to the sta-
bilising Phe and Asn respectively (Ryan and O'Fágáin, in
preparation). Mutant 4 (Mutant 3 with reversion at posi-
tion 283) displayed a 2.6-fold increase in t1/2 at 50°C over
Mutant 3 and a 1.3-fold increase versus wildtype. How-
ever, Mutant 1 (Arg at position 283) and Mutant 2 (rever-
sion at position 283) displayed very similar thermal
stabilities. Solvent stability was also affected by reversion
to Arg at position 283: Mutant 2 exhibited a 1/3 increase
in C50 in DMF, but decreases in DMSO (1/6) and MeOH
(1/5) tolerances compared with Mutant 1. Mutant 4 dis-
played decreased stabilities in DMSO (1/7) and MeOH
(1/5).
Interestingly, both reversion mutants displayed greater
H2O2 stability in free solution than their unreverted coun-
terparts (16% for Mutant 2 versus Mutant 1 and 94% for
Mutant 4 versus Mutant 3; see Tables 1 and 3).
Immobilisation on CNBr-activated Sepharose
Increased lysine content correlated with increased immo-
bilisation on CNBr-activated Sepharose: Mutant 4 (3 sites:
Lys 118, 159, 174; 42% immobilisation) < wildtype (3
sites: Lys 174, 232, 241; 50% immobilisation) < Mutant 3
(4 sites: Lys 118, 159, 174, 283; 57% immobilisation) <
Mutant 2 (5 sites: Lys 118, 159, 174, 232, 241; 69%
immobilisation) < Mutant 1 (6 sites: Lys 118, 159, 174,
232, 241, 283; 86% immobilisation). These calculations
were based on measured units of activity before and after
immobilisation, assuming that no inactivation occurred
during the mild immobilisation process. Immobilised
wildtype demonstrated more than two-fold thermal stabi-
lisation, whilst immobilised Mutant 2 displayed a mar-
ginal 5% increase. Mutant 1 (4-fold), Mutant 3 (1.25-
fold) and Mutant 4(1.25-fold) all displayed decreased
thermal stability following immobilisation.
Solvent stabilities of wildtype and mutant (both free and
immobilised) are set out in Table 2. Small variations (< 2-
fold) in solvent stabilities are noted.
All four mutants and wildtype show a dramatically
decreased resistance to inactivation by H2O2 following
immobilisation onto CNBr-activated Sepharose, approxi-
mating to a basal C50 value of 5 mM H2O2 (Table 3). This
contrasts sharply with variations in H2O2 resistance noted
in free solution (Mutants 2, 1 and 4 display a 2.6, 2.2 and
2-fold increase in stability respectively compared to
wildtype and Mutant 3; Table 3).
Discussion
Lopez-Gallego and co-workers [9] recently proposed
chemical modification to enrich the protein surface with
reactive groups that would facilitate multipoint covalent
attachment during protein immobilisation. The present
work extends this concept by substituting additional
lysines in a specific region of rHRP so as to facilitate
directed, multipoint immobilisation onto a commercially
available, modified polyethersulfone (PES) membrane.
Lysines are often exploited for covalent immobilisation,
as they occur frequently in proteins and are active nucle-
ophiles when unprotonated, i.e. at alkaline pH. They are
usually located on surface-exposed regions of proteins,
due to their charged nature. This characteristic also allows
for simple immobilisation reactions, as lysine residues do
not require activation prior to immobilisation [10]. To
allow directed immobilisation of rHRP to an activated
matrix, arginine residues were selected for conservative
substitution by lysine. Of the twenty-one arginine resi-
dues in rHRP, only three were deemed suitable for the
proposed replacements: Arg118, Arg159 and Arg283 (see
Methods). These positions are located on the opposite
side of the molecule to the active site; hence, immobilisa-
tion via these "new" lysines forces the protein to orientate
its active site away from the membrane and towards the
bulk solution. Maximal colour development was noted
during DAB catalysis for Mutant 3 (Lys 118, 159, 174 and
283 available), which can bind only in a uni-directional
manner: the reactive wildtype lysines 232 and 241 [8], on
a different face of the molecule, have been removed. This
directional immobilisation should allow optimal sub-
strate access and product egress.
Although introduction of additional lysines permits direc-
tional immobilisation, a stability penalty is incurred.
Despite its conservative nature, an Arg-to-Lys substitution
can alter hydrogen bonding, as lysine can form only a sin-
gle hydrogen bond compared with Arg [11]. Reduced
hydrogen bonding resulting from the loss of three Arg,
Table 2: % Relative densitometrical analysis of modified PES 
immobilisation
Name % Relative Densitometry Values
Plant 94
WT 100
Mutant 1 127
Mutant 2 140
Mutant 3 163
Mutant 4 138
Plant, WT, Wildtype; Mutant 1, R118K/R159K/R283K; Mutant 2, 
R118K/R159K; Mutant 3, R118K/R159K/K232N/K241F/R283K; 
Mutant 4, R118K/R159K/K232N/K241F. % values were calculated 
using the 'Analyse' function of ImageJ software package [35].BMC Biotechnology 2007, 7:86 http://www.biomedcentral.com/1472-6750/7/86
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Scanned images of DAB-stained, spotted immobilised rHRP activity Figure 2
Scanned images of DAB-stained, spotted immobilised rHRP activity. WT, Wildtype; Mutant 1, R118K/R159K/R283K; Mutant 2, 
R118K/R159K; Mutant 3, R118K/R159K/K232N/K241F/R283K; Mutant 4, R118K/R159K/K232N/K241F. Time points indicated 
on the left are in hours. DAB coloration indicates peroxidase activity; this was noted within minutes for the immobilisation 
mutants, whereas plant and wildtype recombinant HRP required a longer time to develop any coloration.
Mutant 3 Plant WT  Mutant 1 Mutant 2 Mutant 4
T = 0
T = ⅓
T = 1
T = 2
T = 3
T = 4
T = 18BMC Biotechnology 2007, 7:86 http://www.biomedcentral.com/1472-6750/7/86
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coupled with substitution by a bulky aromatic Phe
(K232F) residue, may explain the instability of Mutant 3
in free solution. Arg283 is located on the last turn of Helix
J [12]. Simple reversion of this residue rescued (or even
enhanced) poor thermal and H2O2  stabilities of the
R283K rHRP mutant. Whilst this reversion reduced the
number of potential immobilisation sites, the stabilising
effect of the K232F and K241N mutations (Ryan and
O'Fágáin, in preparation) was evidenced (Table 2; Mutant
4 versus Mutant 2 in free solution). Further protein engi-
neering is required to re-introduce stability to the immo-
bilisation mutants. The work of Strausberg and co-
workers [13] has parallels with the present study. They
removed a Ca2+ binding loop from subtilisin so as to
enhance its stability under metal-chelating conditions.
Their initial "loop-less" mutant was much less stable than
the wildtype, but it proved possible to "retro-engineer"
stability into the mutant, such that it out-performed
wildtype under chelating conditions.
Currently, there are very few reports of either direct or ran-
dom immobilisation of recombinant HRP in the litera-
ture. Rojas-Melgarejo and colleagues [2] noted the
difficulty in immobilising recombinant HRP expressed in
E. coli to traditional adsorbent solid phases, since it lacks
the carbohydrate residues commonly used for this type of
immobilisation. Instead, cinnamic esters were success-
fully employed (63% immobilisation rate) as an immobi-
lisation platform using physical adsorption in
conjunction with glycosylation-independent hydropho-
bic interaction. Wildtype recombinant HRP immobilised
in such a fashion yielded an 8% increase in thermal stabil-
ity. Abad and co-workers [14] recently described directed
recombinant HRP immobilisation via an N-terminal His
tag-cobalt (II)-terminated gold nanoparticle interaction.
Although no stability data were reported for this method,
its potential application in the convenient attachment of
rHRP onto gold electrodes for biosensing is obvious.
Although our rHRP possesses a C-terminal His Tag, we
chose not to exploit this feature for immobilisation and
instead adopted the strategy outlined here.
The immobilisation of enzymes can increase protein sta-
bility [15]; however, by implementing orientation-
dependent protein immobilisation, researchers may not
only stabilise a protein, but also promote superior per-
formance in applications such as biosensors. Recent
developments in the biosensing area focus on the type of
bio-recognition involved in immobilisation. Tradition-
ally, lysines (as in this study) or cysteines can be engi-
neered into a protein backbone to allow for
immobilisation; however, research has progressed
towards controlled deposition and orientation of immo-
bilised recombinant oxidoreductases for optimal Direct
Electron Transfer (DET). The shorter the electron transfer
distance, the greater the chance of DET occurring in a bio-
sensor configuration; hence, controlled directional immo-
bilisation of enzymes is important for the progression of
third generation biosensors. Typically, physical adsorp-
tion is utilised for peroxidase immobilisation onto a
metal electrode; however, other methods such as entrap-
ment [16] and direct covalent attachment [17] are
employed. Often, these methods lead to the formation of
a randomly orientated layer, either on the surface of the
electrode (metal) or within cavities (carbon). Physical
adsorption may result in enzyme denaturation, due to
multiple contacts with the solid phase. Binding of ligands,
or substrate/product access and egress, may also be hin-
Table 3: Stability Characteristics of HRP Immobilisation Mutants in free solution and immobilised on CNBr-activated Sepharose
Thermal Stability Solvent and H2O2 Stability
Mutant T50 (°C) k-value (min-1) SD (min-1) t1/2 (min) DMSO C50 MeOH C50 DMF C50 H2O2 C50
Free Solution
WT 50 0.0559 ± 0.0034 12 35 53 14 17
Mutant 1 51 0.0535 ± 0.0005 12 34 44 12 38
Mutant 2 50 0.0568 ± 0.0057 12 30 35 16 44
Mutant 3 48 0.0109 ± 0.0007 6 35 45 25 17
Mutant 4 50 0.0445 ± 0.0003 17 30 35 16 33
Immobilised
WT - 0.0255 ± 0.0023 27 32 40 14 6
Mutant 1 - 0.0223 ± 0.0020 3 24 32 17 5
Mutant 2 - 0.0544 ± 0.0044 13 28 38 10 5
Mutant 3 - 0.0152 ± 0.0017 5 42 43 29 5
Mutant 4 - 0.0491 ± 0.0049 14 28 38 15 5
WT, Wildtype; Mutant 1, R118K/R159K/R283K; Mutant 2, R118K/R159K; Mutant 3, R118K/R159K/K232N/K241F/R283K; Mutant 4, R118K/
R159K/K232N/K241F. Modelled k-values were calculated using the Enzfitter™ software package (Version 1.05. Cambridge UK: Biosoft Ltd.; 1987). 
Values are the mean of three independent determinations in each case. Standard deviations were < 5% for solvent and < 10% for H2O2 studies. 
Units of C50 are % v/v for solvents and mM for H2O2.BMC Biotechnology 2007, 7:86 http://www.biomedcentral.com/1472-6750/7/86
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dered, all resulting in poor bioelectrocatalytic activity
[18]. Self-assembled monolayers (SAM) are an attractive
alternative for controlled, directed enzyme immobilisa-
tion. These highly organised monomolecular layers form
spontaneously upon submersion of a solid phase into a
solution containing amphifunctional molecules. The
lengthy hydrophobic chain of the SAM can be altered and
terminated with a functional group that will interact only
with a specific residue on an enzyme backbone [19]. In
this instance, a site directed mutation could be utilised to
dictate the location of the specific residue and, hence, con-
trol the orientation of the molecule (e.g additional Cys
residue for thiol immobilisation [20]). This concept has
recently been adapted for use with chemically-modified
plant-derived HRP by Suarez and co-workers [21].
Other methods of immobilisation have developed in
recent years, from His-tag chelation to biotin-avidin inter-
action. Polypeptide scaffolds comprise a topical generic
immobilisation method, employing a hydrophobic
anchor attached to a leucine-zipper protein capture
domain utilised to directionally immobilise several differ-
ent proteins to a hydrophobic solid phase [22].
Fuentes and colleagues [23] recently noted that the rate of
plant HRP immobilisation depended exponentially on
the concentration of reactive groups both on the protein
and the support. Hence, a protein is mainly immobilised
by an area of its surface having the highest density of reac-
tive groups. Lysine is the key amino acid responsible for
protein immobilisation onto CNBr-activated Sepharose
[24], as reflected in the present study. Only bound Mutant
4 displayed improved stability over free-solution figures,
suggesting that multipoint attachment, most evident in
the case of Mutant 1, increases strain on the rHRP mole-
cule. This, combined with restricted flexibility, leads to a
notable decrease in thermal stability for the mutants. Pre-
vious reports of destabilising multipoint immobilisation
of glucoamylase also cite increased protein strain as rea-
son for decreased thermal stability [25], while the type of
immobilisation resin can also destabilise the immobilised
protein [26]. Our results contrast with previous reports of
increased thermal stability following multipoint attach-
ment [6]. However, Abian and co-workers [6] focused
their mutations on a lysine-rich area of Pencillin G Acy-
lase, which previous chemical modification studies had
proven not to be critical for protein stability, and so min-
imised the chance of a deleterious mutation in this area.
This group also utilised a glyoxyl agarose-activated solid
phase for protein immobilisation. Plant-derived glyco-
sylated HRP has previously been immobilised onto a vari-
ety of solid phases, by a range of different techniques, to
increase thermal stability. For example, Rojas-Melgarejo
and co-workers [27] noted increased thermal stability
(30%) for plant HRP absorbed onto cinnamic carbohy-
drate esters, similar to that noted in this study for wildtype
rHRP (27%), covalently immobilised onto CNBr-acti-
vated Sepharose.
The reduced solvent stabilities of the mutants can simi-
larly be ascribed to increased strain and lack of protein
flexibility. Due to the confined nature of the immobilised
protein, organic solvent molecules that have stripped and
replaced water molecules are maintained in close proxim-
ity to the protein surface, leading to accelerated protein
denaturation [27]. It is well known that many enzymes
can function in organic solvents [28]; however, protein
denaturation often occurs in water-miscible solvents, by a
process referred to as "water-stripping". Gorman and
Dordick [29] described how T2O (tritiated water) is des-
orbed from HRP by organic solvents such as MeOH and
DMF. DMF, despite its higher dielectric constant, des-
orbed significantly less T2O than did MeOH. The differ-
ence is possibly due to structural similarities between
MeOH and H2O, which allow MeOH to strip and replace
water molecules close to the protein surface. There is a
major requirement for water for HRP activity [29], so any
water removal will have a detrimental effect on enzyme
activity. Small losses of solvent stability (e.g. Mutant 3)
can be attributed to the reduced number of potential
attachments for covalent immobilisation. Hence, the
immobilisation of Mutant 3 is not as rigid as that of
Mutant 1, permitting some protein flexibility.
Immobilisation on CNBr-activated Sepharose notably
decreased H2O2 tolerance of rHRP wildtype and mutants:
the basal C50 value was 5 mM H2O2, much lower than any
free-solution value. Previous immobilised HRP H2O2 tol-
erance results depend on the type and reactivity of the
activated solid phase. Rojas-Melgarejo and co-workers
[27] report increased H2O2 tolerance for HRP adsorbed
onto cinnamic carbohydrate esters when the stability
analysis was carried out at pH 7.0; at pH 4.5, however,
there was a dramatic loss of H2O2 stability. Those authors
believe that reactive oxygen species such as superoxide,
generated during H2O2 catalysis, may have been absorbed
by the cinnamic support at pH 7.0 instead of attacking the
essential enzyme residues. At lower pH, however, carbo-
nyl groups are oxidised and do not provide a sink for oxi-
dising reactive oxygen species, leading to dramatic
enzyme destabilisation [27].
Conclusion
Directional orientated immobilisation of rHRP mutants
onto an activated, modified polyethersulfone (PES) mem-
brane has been achieved with excellent retention of cata-
lytic activity. Despite some loss of thermal, solvent and
H2O2  stabilities both in free solution and following
immobilisation onto CNBr-activated Sepharose, orien-
tated rHRP immobilisation has many potential applica-BMC Biotechnology 2007, 7:86 http://www.biomedcentral.com/1472-6750/7/86
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tions including diagnostics and biosensor development.
Ultimately, use in these applications will require re-engi-
neering acceptable stability characteristics into the
"immobilisation mutants".
Methods
Materials
The HRP gene was a generous gift from Prof. Frances H.
Arnold (Caltech, CA, USA). The pQE60 vector was pur-
chased from Qiagen (Valencia, CA); XL 10 Gold cells and
QuickChange™ Mutagenesis Kit were purchased from
Stratagene (La Jolla, CA). Pall UltraBind™ PES modified
membranes were obtained from AGB Scientific (Dublin,
Ireland). All other reagents (including CNBr-activated
Sepharose) were purchased from Sigma Aldrich and were
of analytical grade or higher.
Cloning
The HRP gene was directionally cloned into the pQE60
vector as a fusion with the N-terminal pectate lyase (PelB)
leader sequence [30] and a C-terminal hexa-histidine
purification tag, to generate the plasmid pBR_I. Initially,
the PelB leader was cloned via a Nco I – BamH I double
restriction. This introduced a novel Not I site 5' to the
existing BamH I site in the modified pQE60 vector. The
HRP gene was then Not I – Bgl II directionally cloned into
a Not I – BamH I restricted PelB-modified pQE60 vector.
This cloning strategy incorporated the poly-His tag,
present in the pQE60 vector, at the C-terminus of HRP.
Bacterial Strains and Plasmids
E.coli XL 10 Gold was used as host strain to express the
HRP protein. The plasmid (pBR_I), carrying the HRP gene
and coding for the HRP fusion protein, was used for
expression and site directed mutagenesis.
Recombinant DNA Techniques
All DNA manipulations were carried out by standard tech-
niques [31]. Site directed mutagenesis was carried out as
described by Wang and Malcom [32] utilising the Quick-
Change™ method. Mutant primers were supplied by
MWG-Biotech (Germany). Mutations were confirmed by
commercial di-deoxy sequencing (Fusion Antibodies, Bel-
fast, Northern Ireland).
Expression and Purification
A single cell transformed with pBR_I (or mutant deriva-
tive) was grown in LB medium containing 100 µg/mL
ampicillin and 2% w/v glucose until the OD600 nm reached
0.4; the cells were removed via centrifugation at 2,000 × g
for 5 min and resuspended in fresh LB supplemented with
100 µg/mL ampicillin, 1 mM δ-ALA and 2 mM CaCl2. The
cells were then allowed to grow at 30°C, 220 rpm for 16
h. Following overnight expression, the cells were centri-
fuged at 2,000 × g for 5 min and the supernatant was
treated with 50% w/v (with respect to the original super-
natant volume) ammonium sulphate for 2 h at room tem-
perature. The cells were periplasmically lysed [33] and the
periplasmic contents were similarly treated with ammo-
nium sulphate. Proteins precipitated by 50% w/v ammo-
nium sulphate were collected via centrifugation,
resuspended in 50 mM phosphate buffer pH 8.0 and dia-
lysed versus the same buffer overnight at 4°C. Sodium
chloride (1 M) and GnCl (200 mM) were added to the
dialysed fractions, and these latter were subjected to
nickel affinity chromatography at room temperature.
Sodium acetate (25 mM, pH 4.5) was utilised to elute the
bound HRP. The eluted HRP was again dialysed versus 50
mM phosphate buffer pH 7.5 overnight at 4°C, after
which the protein was concentrated (Amicon-Plus 20 con-
centrator tubes), filter sterilised and stored at 4°C.
Substitution residue selection
Arginine residues in the wildtype were pinpointed for
conservative replacement by the reactive side chain lysine,
since both have similar size and charge; this should result
in minimal secondary structure rearrangement [11]. The
twenty-one arginines present in wildtype HRP were
viewed in DeepView [34] and assessed for suitability based
on secondary structure and location. Beta sheet-forming
residues were preferred over alpha-helical ones, and sur-
face-exposed residues were selected in preference to bur-
ied ones. Only residues on the plane opposite to the active
site entrance were considered. These criteria resulted in
the selection of R118, R159 and R283 as targets for
replacement by lysines (see Figure 1). Of the six wildtype
lysines, only 174, 232 and 241 are available for immobi-
lisation under mild conditions [8]. Lys 174, modified to
only 20% compared with 100 and 85% for 232 and 241
[8], was left intact throughout this study, but positions
232 and 241 were altered in some of the mutants (see
Results section and Figure 1).
rHRP immobilisation
(a) Pall UltraBind™
Modified PES Membrane possesses activated aldehyde
functional groups tailored for amine-based covalent
immobilisation. HRP (plant or recombinant) was resus-
pended in 50 mM sodium phosphate buffer, pH 7.5
(enzyme concentration 30 pM), and directly spotted onto
the activated membrane; the latter was allowed to air-dry
completely at room temperature for 10 min. The remain-
ing binding sites were then blocked with 1% w/v solution
of food-grade non-fat dry milk in 50 mM sodium phos-
phate buffer, pH 7.5, for 1 hour at room temperature. The
membrane was then washed with 50 mM sodium phos-
phate buffer, pH 7.5, and allowed to air-dry completely at
room temperature for 10 min. DAB (precipitating chro-
mogen) and TMB (non-precipitating chromogen) were
utilised to locate immobilised HRP prior to imaging.BMC Biotechnology 2007, 7:86 http://www.biomedcentral.com/1472-6750/7/86
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PES Immobilised HRP-Imaging
Developed membranes were imaged with a Hewlett Pack-
ard Scanjet 5590, connected to a Dell Optiplex Computer
with the following parameters: output type, true colour
(24 bit); output scale, 100%; output resolution, 2400 dpi;
sharpen level, extreme; scan form, scanner glass; high-
lights, -100; shadows, -100; and midtones, -100. True col-
our images were converted to greyscale using Hewlett
Packard Scanjet 5590 image software.
Image J Analysis
Saved greyscale images were opened in Image J software
[35]. The background was subtracted from the image
using the Process>subtract background function. A rolling
ball radius of 50 and a white background were selected.
The image threshold was also automatically adjusted to
black and white. The image was cropped and desitometri-
cal analysis carried using the 'Analyse' function. The
results were expressed as a %age of the wildtype value.
(b) CNBr activated Sepharose® 4B
HRP was suspended in coupling buffer (0.1 M NaHCO3/
Na2CO3 containing 0.5 M NaCl, pH 8.5; enzyme concen-
tration 30 pM). CNBr-activated Sepharose® 4B was aliq-
uoted into a clean purification column (2 × 8 cm), then
washed and swollen in cold 1 mM HCl for at least 30 min.
The resin was then washed with 10 column volumes of
distilled water and, finally, with coupling buffer. Immedi-
ately, the resin was transferred to the solution containing
HRP and mixed on an end-over-end rotator for 2 hours at
room temperature. After coupling, any unbound protein
was removed using several washes of coupling buffer. Any
remaining unreacted groups on the Sepharose particles
were blocked with 0.2 M glycine, pH 8, for 2 hours at
room temperature. Extensive washing with high (A: 0.1 M
NaHCO3/Na2CO3 buffer containing 0.5 M NaCl, pH 8.5)
and low (B: 0.1 M acetic acid-sodium acetate buffer, pH 4)
pH buffers, A and B respectively, removed the glycine and
consolidated the HRP-to-resin covalent bonds.
H2O2 and Thermal Tolerance Analysis
H2O2 stability of recombinant HRP, and mutant variants,
was determined as described in ref. [36]. In brief, rHRP
(360 nM in 50 mM phosphate buffer, pH 7.0) was incu-
bated with increasing concentrations of H2O2  (0–100
mM). H2O2 concentrations were determined spectropho-
tometrically at 240 nm using 43.6 M-1cm-1 as the extinc-
tion coefficient [37]. Samples were exposed to the relevant
H2O2 concentration for 30 min at 25°C in a temperature-
controlled waterbath. Residual catalytic activities were
then measured (below) (note that the H2O2 concentration
used with a reducing co-substrate in the activity assay
below was significantly lower than the concentration of
H2O2 as sole substrate that led to 50% inactivation (C50)
[38]). The thermal stability parameters of recombinant
HRP and mutant variants were determined as follows. A
single peroxidase stock solution was placed for 10 min at
progressively increasing temperatures, at which time aliq-
uots were withdrawn, chilled on ice and eventually
assayed under optimal conditions. This procedure gives
T50, or the temperature of 50% inactivation. For thermal
inactivation at a constant 50°C, a single peroxidase stock
solution (room temperature) was plunged into a water-
bath held at 50°C and aliquots were withdrawn every
minute for ten minutes onto ice and later assayed under
optimal conditions. The solvent parameters of recom-
binant HRP and mutant variants were determined as
described for plant HRP [39] except that the solvents
employed were methanol, dimethylsulfoxide and dimeth-
ylformamide.
Following temperature, solvent or H2O2 incubation, aliq-
uots (50 µL) were withdrawn and the remaining catalytic
activities were assayed using a standard microtitre-based
TMB assay. This comprised 150 µL of 32 mM TMB sub-
strate (in 100 mM citric acid buffer, pH 5.5, containing 3
mM H2O2) and 50 µL of rHRP in each well. The micro-
plate was shaken as the initiating enzyme was added and
the absorbance at 620 nm was recorded after 6.5 min reac-
tion time. The C50 value (mM H2O2 or % v/v solvent
where 50% of maximal HRP activity still remains) was uti-
lised to compare H2O2/solvent stabilities across the
mutant matrix, whilst the t1/2 (half-life) was employed to
compare mutant thermal stabilities (see Table 3).
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